SIR-ACTIN
LIVE

Serial Number

79388948

Owner

Spirochrome AG

Attorney

Andrew M. Smith

Filing Date

Nov 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SIR-ACTIN Trademark

Serial Number: 79388948 • Registration: 7656601

SIR-ACTIN is a trademark filed by Spirochrome AG on November 8, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Spirochrome AG (4 trademarks)

Chalberweidstrasse 4

Entity Type: 25

Trademark Details

Filing Date

November 8, 2023

Registration Date

January 21, 2025

Published for Opposition

December 3, 2024

Goods & Services

Biological preparations for use in industry and science; diagnostic preparations for science or research purposes; reagents for research purposes; diagnostic reagents for science or research purposes; diagnostic reagents for in vitro or in vivo use for biochemistry, clinical chemistry, microbiology and cellular biology; reagents for in vitro or in vivo use in laboratories, except for medical or veterinary use; fluorescent chemical preparations used as fluorescent markers for marking proteins in cells for scientific purposes; chemical preparations for marking biomolecules; biomolecules containing reagents intended for scientific research purposes; fluorescent chemical preparations for use in microscopy; fluorescent biomolecules for use in microscopy

diagnostic agents for medical purposes; in-vitro diagnostic preparations for medical use; diagnostic kits containing chemical products in the nature of diagnostic agents, preparations, and substances for medical use; kits comprising diagnostic agents, preparations and substances used for diagnostic purposes and medical use; diagnostic test reagents for medical or veterinary use; diagnostic reagents for medical or veterinary use; biological and chemical reagents for medical or veterinary use; diagnostic biomarking reagents for medical use; medical diagnostic reagents and assays for testing bodily fluids; diagnostic reagents and contrast agents for medical use; contrast media for in-vivo imaging

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 23, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 5, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 5, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 26, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 7, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 7, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 22, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 6, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 5, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 5, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 5, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 5, 2024 CNEA
ASSIGNED TO EXAMINER
Oct 15, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 26, 2024 TROA
REFUSAL PROCESSED BY IB
Aug 17, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 29, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 29, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 2, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jul 1, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 17, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 9, 2024 REPR